Citations

Clear

70 citation(s) found for "Locke, Dona E C".

O4‐04‐06: Preclinical‐stage Alzheimer's disease and measures of depression
Stonnington, Cynthia M. , Caselli, Richard J. , Locke, Dona E.C. , Dueck, Amylou C. , Knopman, David S.

Mayo Clinic

Alzheimer's & Dementia | July 19, 2012 | Volume: 8 | Issue: 4S_Part_17 | Pages: No page available

10.1016/j.jalz.2012.05.2182 Get It

O2‐03‐01: TOMM40, APOE and preclinical memory decline
Caselli, Richard J. , Huentelman, Matthew J. , Saunders, Ann M. , Reiman, Eric M. , Roses, Allen D., Dueck, Amylou C. , Lutz, Michael W. , Locke, Dona E.C.

Mayo Clinic

Alzheimer's & Dementia | August 1, 2011 | Volume: 7 | Issue: 4S_Part_9 | Pages: No page available

10.1016/j.jalz.2011.05.850 Get It

Correlates of quitting the Paced Auditory Serial Addition Test in cognitively normal older adults participating in a study of normal cognitive aging
Locke, Dona E.C. , Stonnington, Cynthia M. , Thomas, Michael L. , Caselli, Richard J. , Locke, Dona E C

Mayo Clinic

Journal of Clinical and Experimental Neuropsychology | June 27, 2011 | Volume: 33 | Issue: 8 | Pages: 937-943

10.1080/13803395.2011.578571 | PMID 21950515 Get It

Longitudinal modeling of frontal cognition in APOE ε4 homozygotes, heterozygotes, and noncarriers
Caselli, Richard J. , Dueck, Amylou C. , Locke, Dona E.C. , Hoffman‐Snyder, Charlene R., Woodruff, Bryan K. , Rapcsak, Steven Z. , Reiman, Eric M. , Dueck, A. C. , Locke, Dona E C

Mayo Clinic

Neurology | April 18, 2011 | Volume: 76 | Issue: 16 | Pages: 1383-1388

10.1212/wnl.0b013e3182167147 | PMID 21502596 Get It

Cerebrovascular risk factors and preclinical memory decline in healthy APOE ε4 homozygotes
Caselli, Richard J., Dueck, Amylou C. , Locke, Dona E.C. , Sabbagh, Marwan N. , Ahern, Geoffrey L., Rapcsak, Steven Z. , Baxter, Leslie C. , Yaari, R. , Woodruff, Bryan K. , Hoffman‐Snyder, Charlene , Rademakers, Rosa , Findley, Scott, Reiman, Eric M. , Baxter, Leslie C. , Dueck, A. C. , Locke, Dona E C

Mayo Clinic

Neurology | February 17, 2011 | Volume: 76 | Issue: 12 | Pages: 1078-1084

10.1212/wnl.0b013e318211c3ae | PMID 21325652 Get It

Estimating the Diagnostic Value of the Trail Making Test for Suboptimal Effort in Acquired Brain Injury Rehabilitation Patients
Powell, Matthew R. , Locke, Dona E.C. , Smigielski, Jeffrey S., McCrea, Michael , Locke, Dona E C

Mayo Clinic

The Clinical Neuropsychologist | November 27, 2010 | Volume: 25 | Issue: 1 | Pages: 108-118

10.1080/13854046.2010.532912 | PMID 21113855 Get It

Initial development of Minnesota Multiphasic Personality Inventory–2–Restructured Form (MMPI–2–RF) scales to identify patients with psychogenic nonepileptic seizures
Locke, Dona E.C. , Thomas, Michael L. , Locke, Dona E C

Mayo Clinic

Journal of Clinical and Experimental Neuropsychology | November 12, 2010 | Volume: 33 | Issue: 3 | Pages: 335-343

10.1080/13803395.2010.518141 | PMID 21069613 Get It

O3‐02‐05: Cognitive correlates of frontotemporal amyloid deposition in presymptomatic APOE e4 carriers
Caselli, Richard J. , Hoffman‐Snyder, Charlene , Findley, Scott, Woodruff, Bryan K. , Reiman, Eric M. , Dueck, Amylou C. , Locke, Dona E.C.

Mayo Clinic

Alzheimer's & Dementia | July 11, 2010 | Volume: 6 | Issue: 4S_Part_4 | Pages: No page available

10.1016/j.jalz.2010.05.401 Get It

Neuropsychological Consequences of Cancer and Cancer Treatment
Kean, Jacob , Locke, Dona E.C.

Mayo Clinic

Perspectives on Neurophysiology and Neurogenic Speech and Language Disorders | December 3, 2008 | Volume: 18 | Issue: 4 | Pages: 144-151

10.1044/nnsld18.4.144 Get It

Abstract Purpose : This review paper was written to facilitate greater understanding of functional cognitive deficits associated with cancer and cancer treatment. Rehabilitation of patients with cancer also has been considered in this review to raise awareness of this potentially underserved population. Method : A review of the literature pertaining to cognitive effects of cancer and cancer therapy was conducted. Results and Conclusions : A growing literature suggests the phenomenon popularly called “chemo brain” results from dysfunction of frontal-subcortical networks and manifests as deficits of executive functioning (e.g., reasoning, decision-making, resource allocation), processing speed, inhibition, and goal-oriented behaviors. Further research is needed, however, to attribute clearly these broad cognitive side effects to the disease process and each of several treatments and to establish the efficacy of cognitive rehabilitation for patients with cancer.
Age, family history, and memory and future risk for cognitive impairment
Locke, Dona E.C. , Ivnik, Robert J., Cha, Ruth H., Tangalos, Eric G., Petersen, Ronald C. , Smith, Glenn E. , Cha, Ruth H., Knopman, David S. , Boeve, Bradley F. , Locke, Dona E C

Mayo Clinic

Journal of Clinical and Experimental Neuropsychology | May 17, 2008 | Volume: 31 | Issue: 1 | Pages: 111-116

10.1080/13803390802020443 | PMID 18608678 Get It